Payment overview · 2025
General Payments
$198.29
12 reported records · 4 companies
Healthcare provider profile · identity verified
Dave K Jain, DO
Allopathic & Osteopathic Physicians|Internal Medicine · KENNETT, MO · NPI 1265540777
Verified facts
What the public records show
CMS Open Payments records show Dave K Jain, DO received $198.29 in general payments during 2025 across 12 reported records.
Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 77.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 199 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $152.86 | 77.1% | 9 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $16.58 | 8.4% | 1 | 2025 |
| Xeris Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $14.61 | 7.4% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $14.24 | 7.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $141.74 | 9 |
| Education | $56.55 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $152.86 | 9 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $16.58 | 1 | 2025 |
Source payment records
|
|||||
| GVOKE HYPOPEN Normalized: gvoke hypopen |
Drug | Xeris Pharmaceuticals, Inc. | $14.61 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $14.24 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 199 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
199 | 34 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 801 | 110 |
| Pantoprazole Sodium | Pantoprazole Sodium | 633 | 101 |
| Amlodipine Besylate | Amlodipine Besylate | 576 | 91 |
| Gabapentin | Gabapentin | 516 | 92 |
| Lisinopril | Lisinopril | 465 | 77 |
| Fenofibrate | Fenofibrate Nanocrystallized | 388 | 59 |
| Losartan Potassium | Losartan Potassium | 305 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 270 | 108 |
| Diclofenac Sodium | Diclofenac Sodium | 253 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 252 | 43 |
| Atorvastatin Calcium | Atorvastatin Calcium | 248 | 48 |
| Meloxicam | Meloxicam | 244 | 49 |
| Furosemide | Furosemide | 225 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 213 | 34 |
| Jardiance | Empagliflozin | 199 | 34 |
| Carvedilol | Carvedilol | 198 | 31 |
| Omeprazole | Omeprazole | 195 | 36 |
| Glipizide Er | Glipizide | 189 | 33 |
| Enalapril Maleate | Enalapril Maleate | 177 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 176 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 174 | 28 |
| Tamsulosin Hcl | Tamsulosin Hcl | 165 | 27 |
| Potassium Chloride | Potassium Chloride | 148 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 146 | 27 |
| Montelukast Sodium | Montelukast Sodium | 144 | 28 |
| Prednisone | Prednisone | 141 | 86 |
| Simvastatin | Simvastatin | 140 | 22 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 137 | 27 |
| Eliquis | Apixaban | 124 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 110 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 110 | 19 |
| Celecoxib | Celecoxib | 107 | 16 |
| Memantine Hcl | Memantine Hcl | 107 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 105 | 21 |
| Donepezil Hcl | Donepezil Hcl | 103 | 22 |
| Tradjenta | Linagliptin | 96 | 14 |
| Spironolactone | Spironolactone | 92 | 16 |
| Levofloxacin | Levofloxacin | 91 | 70 |
| Metoprolol Succinate | Metoprolol Succinate | 91 | 13 |
| Xarelto | Rivaroxaban | 91 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 89 | 14 |
| Cefdinir | Cefdinir | 86 | 75 |
| Buspirone Hcl | Buspirone Hcl | 85 | 17 |
| Allopurinol | Allopurinol | 84 | 13 |
| Glipizide | Glipizide | 83 | 12 |
| Gemfibrozil | Gemfibrozil | 81 | 14 |
| Clonidine Hcl | Clonidine Hcl | 79 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 76 | 59 |
| Azithromycin | Azithromycin | 75 | 66 |
| Warfarin Sodium | Warfarin Sodium | 68 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 67 | 21 |
| Lovastatin | Lovastatin | 66 | suppressed |
| Metformin Hcl | Metformin Hcl | 65 | 11 |
| Naproxen | Naproxen | 63 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 60 | 48 |
| Dexamethasone | Dexamethasone | 60 | 60 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 60 | 13 |
| Propranolol Hcl | Propranolol Hcl | 60 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 59 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 59 | suppressed |
| Ezetimibe | Ezetimibe | 57 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 55 | 50 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | suppressed |
| Sucralfate | Sucralfate | 55 | 17 |
| Repatha Sureclick | Evolocumab | 52 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 50 | suppressed |
| Ranolazine Er | Ranolazine | 50 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 47 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 43 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 41 | suppressed |
| Digoxin | Digoxin | 41 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 41 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 40 | suppressed |
| Myrbetriq | Mirabegron | 39 | suppressed |
| Vascepa | Icosapent Ethyl | 39 | suppressed |
| Etodolac | Etodolac | 38 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 38 | 14 |
| Sotalol | Sotalol Hcl | 38 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 37 | suppressed |
| Hydrocortisone | Hydrocortisone | 36 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 35 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 34 | suppressed |
| Famotidine | Famotidine | 34 | suppressed |
| Synthroid | Levothyroxine Sodium | 34 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 32 | 31 |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 31 | suppressed |
| Finasteride | Finasteride | 30 | suppressed |
| Minoxidil | Minoxidil | 30 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Pregabalin | Pregabalin | 28 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Nabumetone | Nabumetone | 26 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 26 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 25 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 23 | 11 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 23 | suppressed |
| Irbesartan | Irbesartan | 22 | suppressed |
| Entresto | Sacubitril/Valsartan | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Atenolol | Atenolol | 20 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 20 | 13 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 20 | 14 |
| Tresiba Flextouch U-200 | Insulin Degludec | 20 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 18 | suppressed |
| Procto-Med Hc | Hydrocortisone | 18 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 17 | suppressed |
| Cilostazol | Cilostazol | 16 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Glimepiride | Glimepiride | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 15 | suppressed |
| Glyburide | Glyburide | 15 | suppressed |
| Cartia Xt | Diltiazem Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Ozempic | Semaglutide | 14 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Hydroxyurea | Hydroxyurea | 13 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 12 | suppressed |
| Chlordiazepoxide-Clidinium | Chlordiazepoxide/Clidinium Br | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Baclofen | Baclofen | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $198.29 · 12 records | Boehringer Ingelheim Pharmaceuticals, Inc. | Dexcom G6 Transmitter, GVOKE HYPOPEN, JARDIANCE, Kerendia | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error